Fact CheckerSign in

NCT06676605Completed

Impact of Ashwagandha in Obesity Parameters from Mexican Adults

Assessment of Ashwagandha Pills Consumption in the Amelioration of Obesity-associated Parameters in Mexican Adults with Overweight and Obesity

Source: ClinicalTrials.gov · Last updated 6 Nov 2024

Brief summary (registry, in English)

This clinical trial aimed to assess the impact of ashwagandha supplementation on serum lipid concentrations and body composition in Mexican adults with overweight and obesity. It was a double-blind, placebo-controlled pilot study, including adult patients who consumed ashwagandha pills for 40 days after giving informed consent. Two groups were part of the study: an experimental group receiving the supplement and a placebo group. Measurements conducted included anthropometric parameters and blood biochemical parameters.

Status (registry)
Completed
Study type
Interventional
Enrollment
34 (actual)
First submitted
1 Nov 2024
Start date
10 Jan 2023
Primary completion date
31 Mar 2023
Lead sponsor
Ivan Luzardo-Ocampo
Diseases
Obesity
NCT number
NCT06676605

What you commit to

  • Study type: Interventional
  • Participants enrolled: 34
  • From 10 Jan 2023 to the primary completion date, 31 Mar 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants currently taking any other supplements or medications that could interfere with the study outcomes.

Other illness

  • Individuals with known allergies or intolerances to Withania somnifera or starch rice.
  • Individuals with medical conditions that might interfere with the study results or pose a health risk when taking the supplement.

Other

  • Participants who are unable or unwilling to follow the daily supplementation regimen.

Who the study is looking for

  • Participants who are willing to comply with the study guidelines for a 40-day period.
  • Individuals who consent to undergo initial anthropometric and biochemical analyses.
  • Participants willing to follow personalized meal plans.
  • Individuals who agree to receive reminders and monitoring communication via email and/or text messages.

Age in the registry: 29 years to 38 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nutrition Department at Universidad Autonoma de Nuevo Leon
Coordinator of this site? Confirm its status
MonterreyMexicoUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.